Palbociclib + cetuximab versus cetuximab in patients with CDKN2A -altered, anti-PD-1 resistant, HPV-negative head and neck squamous cell carcinoma (HNSCC): A phase 3 trial
Ley, Jessica C., Cohen, Jared, Liu, Jingxia, Thomeczek, Brianne, Oppelt, Peter John, Adkins, Douglas
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article